Anúncio
Anúncio
INKT
MiNK Therapeutics, Inc. Common Stock
12.35
USDPatrocinado
-0.27
-2.14%
08 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
12.35
0.00
+0.04%
Relatórios de Lucros INKT
Rácio de surpresa positiva
INKT separação 10 de 17 últimas estimativas.
59%
Próximo Relatório
Data do Próximo Relatório
16 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.83
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+27.69%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+33.87%
MiNK Therapeutics, Inc. Common Stock earnings per share and revenue
On 14 de nov. de 2025, INKT reported earnings of -0.65 USD per share (EPS) for Q3 25, beating the estimate of -0.87 USD, resulting in a 25.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.83 USD, with revenue projected to reach -- USD, implying an aumentar of 27.69% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were MiNK Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, MiNK Therapeutics, Inc. Common Stock reported EPS of -$0.65, beating estimates by 25.47%, and revenue of $0.00, 0% as expectations.
How did the market react to MiNK Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -3.56%, changed from $13.22 before the earnings release to $12.75 the day after.
When is MiNK Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 16 de mar. de 2026.
What are the forecasts for MiNK Therapeutics, Inc. Common Stock's next earnings report?
Based on 4
analistas, MiNK Therapeutics, Inc. Common Stock is expected to report EPS of -$0.83 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio